Home โบ Eye Care
Eye Care clinical trials recruiting in the U.S.
23 studies for Eye Care are recruiting participants at sites across the United States.
Your eyes are an important part of your health. Eye care means keeping your eyes healthy through good daily habits, regular checkups, and treatment when needed.
Cities with the most studies
By state
- California7 studies
- Florida7 studies
- Illinois4 studies
- Maryland5 studies
- North Carolina4 studies
- Oregon3 studies
- South Carolina3 studies
- Tennessee3 studies
- Texas4 studies
Recently updated studies
Screening for Research Participants
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 100 ยท All sexes ยท Updated Sep 28, 2026 ยท NCT00655096A Phase 1/2 Study in Healthy Volunteers and Participants With Autosomal Dominant Retinitis Pigmentosa (RHO-adRP)
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Sep 24, 2026 ยท NCT07408232Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
RecruitingPhase 3
Ages 50 and older ยท All sexes ยท Updated Sep 24, 2026 ยท NCT07482176Natural History, Pathogenesis, and Outcome of Ocular Disorders
RecruitingObservational study
Ages 2 to 100 ยท All sexes ยท Updated Sep 24, 2026 ยท NCT02821767Analyzing Retinal Microanatomy in Retinopathy of Prematurity to Improve Care
Recruiting
0 Days โ 9 Months ยท All sexes ยท Updated Sep 17, 2026 ยท NCT07738874SGLT2 Inhibitors in Geographic Atrophy
RecruitingPhase 2
Ages 50 and older ยท All sexes ยท Updated Aug 26, 2026 ยท NCT07174687Adaptive Optics Retinal Imaging
RecruitingObservational studyHealthy volunteers welcome
Ages 12 to 120 ยท All sexes ยท Updated Aug 10, 2026 ยท NCT02317328Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration
RecruitingPhase 2
Ages 50 and older ยท All sexes ยท Updated Aug 5, 2026 ยท NCT07630649APPRAISE: Assessment of Pain and Posterior Synechiae Reduction With Atropine, an Investigation of Post-Surgical Eyes
RecruitingPhase 4
Ages 18 and older ยท All sexes ยท Updated Jul 31, 2026 ยท NCT07434635Autologous Serum Tears With Hyaluronate vs Balanced Salt Solution for Moderate-to-Severe Dry Eye
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Jul 24, 2026 ยท NCT07413172Ocular Blood Flow Imaging for Glaucoma Assessment
RecruitingHealthy volunteers welcome
Ages 18 to 88 ยท All sexes ยท Updated Jul 2, 2026 ยท NCT05726058Stem Cell Ophthalmology Treatment Study II
Recruiting
Ages 18 and older ยท All sexes ยท Updated Jun 29, 2026 ยท NCT03011541Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION)
RecruitingPhase 3
Ages 6 and older ยท All sexes ยท Updated Jun 25, 2026 ยท NCT06891443A Phase I Feasibility Study of an Intracortical Visual Prosthesis (ICVP) for People With Blindness
Recruiting
Ages 19 to 70 ยท All sexes ยท Updated Jun 3, 2026 ยท NCT04634383Strategies for Improving Linkage-to-Care After Eye Disease Screening
Recruiting
Ages 60 and older ยท All sexes ยท Updated Apr 29, 2026 ยท NCT06943599RESTORE: Comparing Two Approaches to Repeat TT Surgery Performed by Integrated Eye Care Workers (IECWs)
Recruiting
Ages 18 and older ยท All sexes ยท Updated Apr 13, 2026 ยท NCT07322302Advancing Pediatric Retinal Imaging With Auto-aligned OCT
RecruitingHealthy volunteers welcome
1 Month ยท All sexes ยท Updated Mar 25, 2026 ยท NCT06841575Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
RecruitingPhase 3
All ages ยท All sexes ยท Updated Mar 17, 2026 ยท NCT06911424Assessment of the Ocular Microbiome in Health and Disease
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older ยท All sexes ยท Updated Jan 22, 2026 ยท NCT05414994Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine (SIGHT) 2
Recruiting
Ages 18 and older ยท All sexes ยท Updated Dec 15, 2025 ยท NCT06934577Impact of TRYPTYR on a Patient's Quality of Life and Ability to Perform Work
RecruitingPhase 4
Ages 18 to 75 ยท All sexes ยท Updated Dec 5, 2025 ยท NCT07266948Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
RecruitingPhase 2/3
Ages 18 and older ยท All sexes ยท Updated Feb 25, 2025 ยท NCT06112340IRIS Registry: Intelligent Research in Sight Registry
RecruitingObservational study
6 Months ยท All sexes ยท Updated Jul 12, 2016 ยท NCT02485847From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.